Hostname: page-component-74656f9884-g96k6 Total loading time: 0 Render date: 2026-11-09T18:19:22.827Z Has data issue: false hasContentIssue false
  • English
  • Français

Optimal disease eradication

Published online by Cambridge University Press:  04 October 2007

SCOTT BARRETT  and
MICHAEL HOEL
SCOTT BARRETT
Affiliation:
School of Advanced International Studies, Johns Hopkins University, 1619 Massachusetts Avenue NW, Washington, DC 20036-1984 USA. Tel: (202) 663-5761. Fax (202) 663-5769. Email: sbarrett@jhu.edu
MICHAEL HOEL
Affiliation:
Department of Economics, University of Oslo, P.O. Box 1095 Blindern, N-0317 Oslo, Norway. Tel: 47 22858387. Fax 47 22855035. Email: michael.hoel@econ.uio.no
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Using a dynamic model of the control of an infectious disease, we derive the conditions under which eradication will be optimal. When eradication is feasible, the optimal program requires either a low vaccination rate or eradication. A high vaccination rate is never optimal. Under special conditions, the results are especially stark: the optimal policy is either not to vaccinate at all or to eradicate. Our analysis yields a cost–benefit rule for eradication, which we apply to the current initiative to eradicate polio.

Information

Type
Research Article
Information
Environment and Development Economics , Volume 12 , Issue 5: SPECIAL ISSUE ON INFECTIOUS DISEASES , October 2007 , pp. 627 - 652
Copyright
2007 Cambridge University Press

Footnotes

We are grateful to Atle Seierstad for helpful discussions and to two anonymous reviewers for comments on an earlier version of this paper.